|
Volume
7 Number 3
March 2019
|
|
Home
>
Disciplines
>
Publications
>
Prostate
Cancer Research
>
Volume
7, Year 2019
>
Number 3, March
|
|
|
CONTENTS
|
▼
|
|
DIAGNOSIS
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
FOLLOW-UP,
QUALITY OF LIFE
INTEGRATIVE
MEDICINE
OVERALL
MANAGEMENT
PROGNOSIS
TREATMENT
|
|
|
DIAGNOSIS
|
▲
|
.
|
Billis A, Freitas LLL, Costa LBE, Barreto IS, Magna LA, Matheus
WE, Ferreira U.
The TNM 8th edition: Validation of the
proposal for organ - confined (pT2) prostate cancer.
Int
Braz J Urol. 2018 Nov 30;45. doi:
10.1590/S1677-5538.IBJU.2018.0338. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Boesen L, Nørgaard N, Løgager V, Balslev I, Bisbjerg
R, Thestrup KC, Winther MD, Jakobsen H, Thomsen HS.
Assessment
of the Diagnostic Accuracy of Biparametric Magnetic Resonance
Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric
MRI for Detection of Prostate Cancer (BIDOC) Study.
JAMA
Netw Open. 2018 Jun 1;1(2):e180219. doi:
10.1001/jamanetworkopen.2018.0219.
Source
.
Similar
articles
|
|
|
.
|
Calais J, Czernin J, Fendler WP, Elashoff D, Nickols NG.
Randomized prospective phase III trial of 68Ga-PSMA-11
PET/CT molecular imaging for prostate cancer salvage radiotherapy
planning [PSMA-SRT].
BMC Cancer.
2019 Jan 7;19(1):18. doi: 10.1186/s12885-018-5200-1. Erratum in:
BMC
Cancer.
2019 Jan 21;19(1):97.
Source
.
Similar
articles
|
|
|
.
|
Ferraro DA, Rupp NJ, Donati OF, Messerli M, Eberli D, Burger IA.
68Ga-PSMA-11 PET/MR Can Be False Positive in Normal
Prostatic Tissue.
Clin Nucl Med. 2019 Jan 1. doi:
10.1097/RLU.0000000000002473. [Epub ahead of print] -
Source
.
Similar
articles
|
|
|
.
|
Gordetsky JB, Ullman D, Schultz L, Porter KK, Del Carmen Rodriguez
Pena M, Calderone CE, Nix JW, Ullman M, Bae S, Rais-Bahrami S.
Histologic findings associated with false-positive
multiparametric magnetic resonance imaging performed for prostate
cancer detection.
Hum Pathol. 2019 Jan;83:159-165. doi:
10.1016/j.humpath.2018.08.021. Epub 2018 Sep 1.
Source
.
Similar
articles
|
|
|
.
|
Jilg CA, Drendel V, Rischke HC, Beck TIR, Reichel K, Krönig
M, Wetterauer U, Schultze-Seemann W, Meyer PT, Vach W.
Detection
Rate of 18F-choline-PET/CT and
68Ga-PSMA-HBED-CC-PET/CT for Prostate
Cancer Lymph Node Metastases with Direct Link from PET to
Histopathology: Dependence on the Size of Tumor Deposits in Lymph
Nodes.
J Nucl Med. 2019 Jan 25. pii: jnumed.118.220541.
doi: 10.2967/jnumed.118.220541. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M,
Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL,
Turkbey B.
A Grading System for the Assessment of Risk of
Extraprostatic Extension of Prostate Cancer at Multiparametric
MRI.
Radiology. 2019 Jan 22:181278. doi:
10.1148/radiol.2018181278. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Shah PH, Patel VR,
Moreira DM, George AK, Alom M, Kozel Z, Joshi V, Ben-Levi E,
Villani R, Yaskiv O, Kavoussi LR, Vira M, Olsson CO, Rastinehad
AR.
Implementation of multiparametric magnetic resonance
imaging technology for evaluation of patients with suspicion for
prostate cancer in the clinical practice setting.
BJU
Int. 2019 Feb;123(2):239-245. doi: 10.1111/bju.14515. First
published: 16 August 2018.
Source
.
Similar
articles
|
|
|
.
|
Zhang J, Shao S, Wu P, Liu D, Yang B, Han D, Li Y, Lin X, Song W,
Cao M, Zhang J, Kang F, Qin W, Wang J.
Diagnostic
performance of 68Ga-PSMA PET/CT in the
detection of prostate cancer prior to initial biopsy: comparison
with cancer-predicting nomograms.
Eur J Nucl Med Mol
Imaging. 2019 Jan 11. doi: 10.1007/s00259-018-4255-1. [Epub ahead
of print]
Source
.
Similar
articles
|
|
|
ETIOLOGY,
PATHOGENESIS, PATHOLOGY
|
▲
|
.
|
Cheng Y, Tang XY, Li YX,
Zhao DD, Cao QH, Wu HX, Yang HB, Hao K, Yang Y.
Depression-Induced Neuropeptide Y Secretion Promotes
Prostate Cancer Growth by Recruiting Myeloid Cells.
Clin
Cancer Res. 2018 Nov 30.
doi: 10.1158/1078-0432.CCR-18-2912. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
FOLLOW-UP,
QUALITY OF LIFE
|
▲
|
.
|
Robinson D, Garmo H, Van Hemelrijck M, Damber JE, Bratt O,
Holmberg L, Wahlund LO, Stattin P, Adolfsson J.
Androgen
deprivation therapy for prostate cancer and risk of dementia.
BJU
Int. 2019 Jan 13. doi: 10.1111/bju.14666. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Sureda A, Fumadó L, Ferrer M, Garín O, Bonet X,
Castells M, Mir MC, Abascal JM, Vigués F, Cecchini L,
Suárez JF.
Health-related quality of life in men
with prostate cancer undergoing active surveillance versus radical
prostatectomy, external-beam radiotherapy, prostate brachytherapy
and reference population: a cross-sectional study.
Health
Qual Life Outcomes. 2019 Jan 14;17(1):11. doi:
10.1186/s12955-019-1082-4.
Source
.
Similar
articles
|
|
|
INTEGRATIVE
MEDICINE
|
▲
|
.
|
Gregg JR, Zheng J, Lopez DS, Reichard C, Browman G, Chapin B, Kim
J, Davis J, Daniel CR.
Diet quality and Gleason grade
progression among localised prostate cancer patients on active
surveillance.
Br J Cancer. 2019 Jan 25. doi:
10.1038/s41416-019-0380-2. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Hao Q, Gong H, Zong H, Huang S, Wang T, Zhou Y, Zhang Y, Zhang Y.
Aspirin use improves the biochemical control of prostate
cancer in Chinese men.
J BUON. 2018
Nov-Dec;23(6):1803-1808.
Source
.
Similar
articles
|
|
|
.
|
Kukko V, Kaipia A, Talala K, Taari K, Tammela TLJ, Auvinen A,
Murtola TJ.
Allopurinol and the risk of prostate cancer
in a Finnish population-based cohort.
Prostate Cancer
Prostatic Dis. 2019 Jan 29. doi: 10.1038/s41391-019-0129-2. [Epub
ahead of print]
Source
.
Similar
articles
|
|
|
OVERALL
MANAGEMENT
|
▲
|
.
|
Osowiecka K, Nawrocki S, Kurowicki M, Rucinska M.
The
Waiting Time of Prostate Cancer Patients in Poland.
Int
J Environ Res Public Health. 2019 Jan 26;16(3). pii: E342. doi:
10.3390/ijerph16030342.
Source
.
Similar
articles
|
|
|
PROGNOSIS
|
▲
|
.
|
Kim R, Kim CK, Park JJ, Kim JH, Seo SI, Jeon SS, Lee HM.
Prognostic Significance for Long-Term Outcomes Following
Radical Prostatectomy in Men with Prostate Cancer: Evaluation with
Prostate Imaging Reporting and Data System Version 2.
Korean
J Radiol. 2019 Feb;20(2):256-264. doi: 10.3348/kjr.2018.0613.
Source
.
Similar
articles
|
|
|
.
|
Li T, Sun X, Chen L.
Free testosterone value before
radical prostatectomy is related to oncologic outcomes and
post-operative erectile function.
BMC Cancer.
2019 Jan 18;19(1):87. doi: 10.1186/s12885-018-5148-1.
Source
.
Similar
articles
|
|
|
.
|
Martini A, Gupta A, Cumarasamy S, Lewis SC, Haines KG 3rd,
Briganti A, Montorsi F, Tewari AK.
Novel nomogram for the
prediction of seminal vesicle invasion including multiparametric
magnetic resonance imaging.
Int J Urol. 2019 Jan 18.
doi: 10.1111/iju.13905. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Mima T, Ohori M, Hirasawa Y, Mikami R, Arai A, Hashimoto T, Satake
N, Gondo T, Nakagami Y, Namiki K, Tokuuye K, Ohno Y.
Salvage
radiation therapy for prostate cancer patients after
prostatectomy.
Jpn J Clin Oncol. 2019 Jan 4. doi:
10.1093/jjco/hyy195. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Viani GA, Hamamura AC, Correa AC, de Arruda FT.
Salvage
radiotherapy for biochemical recurrence after radical
prostatectomy: does the outcome depend on the prostate cancer
characteristics?
Int Braz J Urol. 2019 Jan 5;45. doi:
10.1590/S1677-5538.IBJU.2018.0039. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Yaxley JW, Raveenthiran S, Nouhaud FX, Samartunga H, Yaxley AJ,
Coughlin G, Delahunt B, Egevad L, McEwan L, Wong D.
Outcomes
of Primary Lymph Node Staging of Intermediate and High Risk
Prostate Cancer with 68Ga-PSMA Positron Emission
Tomography/Computerized Tomography Compared to Histological
Correlation of Pelvic Lymph Node Pathology: Can Preoperative
68Ga-PSMA Positron Emission Tomography/Computerized Tomography
Replace Pelvic Lymph Node Dissection for Prostate Cancer Staging?
J Urol. 2019 Jan 21. doi: 10.1097/JU.0000000000000053. [Epub
ahead of print] -
Source
.
Similar
articles
|
|
|
TREATMENT
|
▲
|
.
|
Gupta M, Patel HD, Schwen ZR, Tran PT, Partin AW.
Adjuvant
radiation with androgen-deprivation therapy for men with lymph
node metastases after radical prostatectomy: identifying men who
benefit.
BJU Int. 2019 Feb;123(2):252-260. doi:
10.1111/bju.14241. First published: 07 April 2018.
Source
.
Similar
articles
|
|
|
.
|
Hawken SR, Spratt DE, Qi J, Linsell SM, Cher ML, Ghani KR, Miller
DC, Montie JE, Morgan TM; Michigan Urological Surgery Improvement
Collaborative.
Utilization of Salvage Radiation Therapy
for Biochemical Recurrence after Radical Prostatectomy.
Int
J Radiat Oncol Biol Phys. 2019 Jan 22. pii: S0360-3016(19)30046-X.
doi: 10.1016/j.ijrobp.2019.01.006. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
.
|
Lumbiganon S, Patcharatrakul S, Khongcharoensombat W, Sangkum P.
Pre- and post-radical prostatectomy testosterone levels
in prostate cancer patients.
Int J Impot Res. 2019 Jan
18. doi: 10.1038/s41443-019-0116-0. [Epub ahead of print]
Source
.
Similar
articles
|
|
|
bottom
|
▲
|
|
|
